ACRS vs LDOS · rev $3.6M vs P/E 16, rev $8.96B
Aclaris Therapeutics Inc (ACRS) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
ACRS currently screens at market cap $615.9M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the ACRS and LDOS stock pages for the full models.
Not investment advice.